But it is the exact benefit the researchers expected to find, and did in fact validate, in the current study
Each dose was held for 4 weeks before escalating
Experimental evidence demonstrated that treatment with (Ex-4)2-Fc promotes the conversion of pro-inflammatory M1 macrophages into anti-inflammatory M2 macrophages, leading to increased expression of anti-inflammatory factors and significant reductions in pro-inflammatory markers
There are also dual and tri-agonists like tirzepatide, which target multiple receptors
Pennisi, M., Lanza, G., Cantone, M., D'Amico, E., Fisicaro, F., Puglisi, V., Vinciguerra, L., Bella, R., Vicari, E., & Malaguarnera, G
The competitive landscape continues to evolve as demand for obesity and diabetes therapies drives large-scale investments in peptide manufacturing assets